|
|
|
|
|
|
|
Athenion consists of a group of associated companies in Switzerland and Germany that develop and market exclusive worldwide license rights for innovative drugs and medical technologies. Founded and managed by a group of experienced professionals from science, industry and finance, Athenion combines the know-how and expertise necessary to transform scientific innovation into successful products.
Building blocks of success
Athenion combines the three essential building blocks for bringing new drugs, technologies and products to the pharmaceutical and health care market.
|
|
|
What we do
We scout and identify promising drug developments and technologies primarily from novel sources beyond Western Europe and North America.
The inventors and licensors of our portfolio products are individual scientists, academic research institutions and companies that usually lack the financial, regulatory or business means to develop their products to the point of out-licensing or marketing in the world's major health care markets.
Athenion has established a close-knit network of scientific and business relations to academic research institutions, companies and individual scientists in a number of countries with outstanding scientific resources but limited access to major global markets. The origin of our product portfolio lies e.g. in Eastern Europe and Asia.
|
|
|
|
|